Medicare Drug Price Control Group Formed At CMS: How Will Stakeholders Interact?

As the Centers for Medicare and Medicaid Services begins the process of building new price negotiation and inflation rebate programs within Medicare, stakeholders are watching to see how transparent the process will be and how much outside input the agency will seek.

CMS New Pricing Programs Beginning To Take Shape • Source: Shutterstock

The Centers for Medicare and Medicaid Services has established a Medicare Drug Rebate and Negotiations Group within the Center for Medicare to implement price negotiation and inflation rebate programs for drugs covered under Medicare Parts B and D, the agency announced on 12 October.

As authorized by the Inflation Reduction Act , the new group will negotiate prices with manufacturers for selected older, single-source...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Medicare

More from Government Payers